Shuttle Executes LOI with Molecule.ai

Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) (“Shuttle Pharma” or the “Company”), a discovery and development stage ...

Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next ...

Detailed price information for Candel Therapeutics Inc (CADL-Q) from The Globe and Mail including charting and trades.

Discovery of bitter taste receptors in cancer cells could prevent multidrug resistance

A research team from the Department of Bioscience, Faculty of Life Sciences, Okayama University of Science, has made a ...
TipRanks on MSN

Candel Therapeutics announces it will deliver three presentations at SITC

Candel Therapeutics (CADL) announced it will deliver three presentations at the Society for Immunotherapy of Cancer, SITC, 40th Anniversary Annual ...
PharmiWeb

Ignite Biomedical and Liquid Biosciences Announce the Discovery of Biomarkers for the Diagnosis and Treatment of Autism Spectrum Disorder

Biomarker discovery opens the way for development of novel transformational technology in Autism Spectrum Disorder. FRAMINGHAM, MA / ACCESS Newswire / November 4, 2025 / Ignite Biomedical, Inc.

Certara Automates Scientific Workflows with Phoenix® Cloud

As the inaugural cloud-native module of Phoenix Cloud, TFL Studio sets the stage for future innovations, including the AI PK Reports module described above. It integrates with Integral™, Certara’s ...